Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04978571 · ClinicalTrials.gov registry record · NA
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
A NA study of COVID-19 and Post-Concussion Syndrome, sponsored by Children's Hospital of Orange County.
- Recruiting
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT04978571: Recruiting NA study of COVID-19 and Post-Concussion Syndrome, sponsored by Children's Hospital of Orange County.
NCT04978571 is a NA study of COVID-19 and Post-Concussion Syndrome that is actively recruiting participants, run by Children's Hospital of Orange County. The registered enrollment target is 125 participants, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04978571, a NA study of COVID-19 and Post-Concussion Syndrome, is actively recruiting participants, sponsored by Children's Hospital of Orange County.
- RECRUITING
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the effect of Auricular Percutaneous Electrical Nerve Field Stimulation (a Neurostim device) on children with pain and Post Concussion symptoms. An additional purpose of this study is to demonstrate that PENFS improves functioning in children with post Covid-19 symptoms.
Primary Outcome
With the Immediate Post-Concussion Assessment, percentiles indicate functioning assessment after a concussion. Having a higher score on this assessment implies having a worse outcome assessment.
Conditions Studied
Interventions
- DEVICE percutaneous electrical nerve-field stimulation, PENFS
- DEVICE percutaneous electrical nerve-field stimulation, PENFS (sham device)
- DEVICE percutaneous electrical nerve-field stimulation, PENFS (COVID active device)
Study Locations (1)
California
- CHOC Children's - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT04978571 shows while recruiting
NCT04978571 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with COVID-19 appearing as the primary indexed condition, and to 3 interventions - of which percutaneous electrical nerve-field stimulation, PENFS is the first listed.
NCT04978571 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04978571 about?
NCT04978571 is a clinical study titled "Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)". The purpose of this study is to test the effect of Auricular Percutaneous Electrical Nerve Field Stimulation (a Neurostim device) on children with pain and Post Concussion symptoms. An additional purpose of this study is to demonstrate that PENFS improves functioning in children with post Covid-19 ...
What is the current status of trial NCT04978571?
This trial is currently recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2021-02-01. Estimated completion is 2027-01.
What conditions does trial NCT04978571 study?
This clinical trial studies the following conditions: COVID-19, Post-Concussion Syndrome, COVID Long-Haul.
What interventions are being tested in trial NCT04978571?
The interventions under investigation include: percutaneous electrical nerve-field stimulation, PENFS (DEVICE), percutaneous electrical nerve-field stimulation, PENFS (sham device) (DEVICE), percutaneous electrical nerve-field stimulation, PENFS (COVID active device) (DEVICE).
Who is sponsoring clinical trial NCT04978571?
This trial is sponsored by Children's Hospital of Orange County, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04978571 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04978571's enrollment target sits among peer trials
125 187th of 298 higher than 112 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Music Mindfulness Study 2a.
RECRUITING · NA
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Evaluating the Impact of Social Music
RECRUITING · NA
-
The SINCERE Intervention to Address COVID-19 Health Disparities
RECRUITING · NA
-
Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI